RISK OF THROMBOEMBOLISM IN CHRONIC KIDNEY DISEASE PATIENTS WITH NON VALVULAR ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/vb1a1q77Keywords:
Thromboembolism, chronic kidney disease, non-valvular atrial fibrillationAbstract
Background: Individuals with CKD are at higher risk for thromboembolic events than those without CKD whilst also at a higher bleeding risk. NVAF often coexist with CKD and heightens the risk of one another. This study aimed to investigate the risk of thromboembolism in CKD patients with NVAF.
Methods: This systematic review used Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 as standards. Inclusion criteria for literature eligibility are full-text literature, written in english, and published between 2014 and 2024. Exclusion criteria used for this study were editorials, review articles and identical journal that has been published, and submissions without DOI. Literatures were collected from online reference sources like Pubmed and SagePub.
Result: In the PubMed database, the results of our search brought up 45 articles, whereas the results of our search on SagePub brought up 382 articles. The results of the search conducted for the last year of 2014 yielded a total 10 articles for PubMed and 12 articles for SagePub. In the end, we compiled a total of 5 papers, 3 of which came from PubMed and 2 of which came from SagePub. We included five research that met the criteria.
Conclusion: The existence of both NVAF and CKD increase the risk of thromboembolic events. There are various modalities to analyze the risk of thromboembolism by assessing risk scores, kidney function, and utilizing transesophageal echocardiography (TEE). In order to prevent ischaemic stroke in NVAF patients, anticoagulants can be administered by in consideration to the kidney function.
References
Ravera M, Bussalino E, Paoletti E, Bellasi A, Di Lullo L, Fusaro M. Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: Do we need a novel risk score calculator? International Journal of Cardiology [Internet]. 2019 Jan 1 [cited 2024 Jan24];274:179–85. Available from: https://www.sciencedirect.com/science/article/pii/S0167527318337471
Lau YC, Proietti M, Guiducci E, Blann AD, Lip GYH. Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease. Journal of the American College of Cardiology [Internet]. 2016 Sep 27 [cited 2024 Jan 24];68(13):1452–64. Available from: https://www.jacc.org/doi/abs/10.1016/j.jacc.2016.06.057
Magnocavallo M, Bellasi A, Mariani MV, Fusaro M, Ravera M, Paoletti E, et al. Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy. Journal of Clinical Medicine [Internet]. 2021 Jan [cited 2024 Jan 24];10(1):83. Available from: https://www.mdpi.com/2077-0383/10/1/83
artins RP, Galand V, Colette E, Behar N, Pavin D, Leclercq C, et al. Defining nonvalvular atrial fibrillation: A quest for clarification. American Heart Journal [Internet]. 2016 Aug [cited 2024 Jan 24];178:161–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0002870316300849
McAlister FA, Wiebe N, Jun M, Sandhu R, James MT, McMurtry MS, et al. Are Existing Risk Scores for Nonvalvular Atrial Fibrillation Useful for Prediction or Risk Adjustment in Patients With Chronic Kidney Disease? Canadian Journal of Cardiology [Internet]. 2017 Feb 1 [cited 2024 Jan 24];33(2):243–52. Available from: https://www.sciencedirect.com/science/article/pii/S0828282X16309369
Kizawa S, Ito T, Akamatsu K, Ichihara N, Nogi S, Miyamura M, et al. Chronic Kidney Disease as a Possible Predictor of Left Atrial Thrombogenic Milieu Among Patients with Nonvalvular Atrial Fibrillation. The American Journal of Cardiology [Internet]. 2018 Dec 15 [cited 2024 Jan 24];122(12):2062–7. Available from: https://www.sciencedirect.com/science/article/pii/S0002914918317636
Loo S, Coulombe J, Dell’Aniello S, Brophy J, Suissa S, Renoux C. Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study. BMJ Open. 2018 Jan 24;8:e019638.
Wang Q, Xie X, Xu G. The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysis. BMC Nephrol [Internet]. 2020 Dec [cited 2024 Jan 18];21(1):106. Available from: https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-020-01757-1
Cha MJ, Cho Y, Oh IY, Choi EK, Oh S. Validation of Conventional Thromboembolic Risk Factors in a Korean Atrial Fibrillation Population ― Suggestion for a Novel Scoring System, CHA2DS2-VAK ―. Circ J [Internet]. 2018 Nov 24 [cited 2024 Jan 25];82(12):2970–5. Available from:
https://www.jstage.jst.go.jp/article/circj/82/12/82_CJ-18-0218/_article
Wang H jun, Li K liang, Li J, Lin K, Shi Y, Wang H, et al. Moderate chronic kidney disease and left atrial enlargement independently predict thromboembolic events and mortality in elderly patients with atrial fibrillation: a retrospective single-center study. J Int Med Res [Internet]. 2019 Sep 1 [cited 2024 Jan 24];47(9):4312–23. Available from: https://doi.org/10.1177/0300060519858151
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
